PetVivo Holdings Inc

PetVivo Holdings: niche veterinary biotech firm with high P/B, negative P/E, volatile OTC stock—investors weigh potential gains against financial uncertainty.

PetVivo Holdings prepares to discuss Q2 2026 earnings on Nov 14, 2025—exploring AI‑driven veterinary tech, new partnerships, and growth prospects for investors.

PetVivo Holdings Inc, a healthcare equipment company focused on treating companion animals, faces financial instability and a negative price-to-earnings ratio, raising questions about its future prospects and ability to balance innovation with profi…

PetVivo Holdings, Inc. is a Minnesota-based holding company dedicated to improving the lives of companion animals through innovative biotech and biomedical devices, particularly for treating conditions such as arthritis in dogs and horses.